Laurie H. Sehn

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Matthew Maurer

Assistant Professor of Biostatistics and Medicine

Mayo Clinic Rochester

UNITED STATES

View details

James Cerhan

Professor of Epidemiology

Mayo Clinic Rochester

UNITED STATES

View details

David W. Scott

The University of British Columbia

CANADA

View details

Kerry J. Savage

CANADA

View details

Lihua Budde

Associate Professor

City Of Hope National Medical Center

UNITED STATES

View details

Andrea C. Lo

CANADA

View details

Francesc Bosch

Professor

Universitat Autònoma de Barcelona Facultat de Medicina

SPAIN

View details

Sung‐Soo Yoon

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Laurie H. Sehn

Research Interests

Explore related searches

Contact this professor

Articles (10)

Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study

Utilization of real‐world data in assessing treatment effectiveness for diffuse large B‐cell lymphoma

Radioimmunotherapy for orbital marginal zone lymphoma: a retrospective review

Clinicopathological characteristics and long‐term outcomes of plasmablastic lymphoma in British Columbia

Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia

PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design

A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies

CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?

Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA

Limited-stage diffuse large B-cell lymphoma

Collaborators (8)

Matthew Maurer

James Cerhan

David W. Scott

Kerry J. Savage

Lihua Budde

Andrea C. Lo

Francesc Bosch

Sung‐Soo Yoon

Make your next move.